STORM Therapeutics

Biotech · Cambridge, GB

Cambridge spin-out developing oncology drugs based on RNA epigenetics (METTL3 inhibitor).

In the network

Shares the most investors with (number = shared investors):

Create a free EquityFlow account to see STORM Therapeutics's 1 funding round, 6 investors, 12 similar companies.